Literature DB >> 1881320

Diffusion/perfusion MR imaging of acute cerebral ischemia.

J Kucharczyk1, J Mintorovitch, H S Asgari, M Moseley.   

Abstract

In vivo echo-planar MR imaging was used to measure apparent diffusion coefficients (ADC) of cerebral tissues in a comprehensive noninvasive evaluation of early ischemic brain damage induced by occlusion of the middle cerebral artery (MCA) in a cat model of acute regional stroke. Within 10 min after arterial occlusion, ADC was significantly lower in tissues within the vascular territory of the occluded MCA than in normally perfused tissues in the contralateral hemisphere. Sequential echo-planar imaging was then used in conjunction with bolus injections of the magnetic susceptibility contrast agent, dysprosium DTPA-BMA, to characterize the underlying cerebrovascular perfusion deficits. Normally perfused regions of brain were identified by a dose-dependent 35-70% loss of signal intensity within 6-8 s of contrast administration, whereas ischemic regions appeared relatively hyperintense. These data indicate that sequential diffusion/perfusion imaging may be useful in differentiating permanently damaged from reversibly ischemic brain tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881320     DOI: 10.1002/mrm.1910190220

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  26 in total

Review 1.  The need for objective assessment of the new imaging techniques and understanding the expanding roles of stroke imaging.

Authors:  W T Yuh; T Ueda; M White; M E Schuster; T Taoka
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

2.  Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

Authors:  Gerlof P Th Bosma; Tom W J Huizinga; Simon P Mooijaart; Mark A Van Buchem
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  A preliminary study of the effects of trigger timing on diffusion tensor imaging of the human spinal cord.

Authors:  P Summers; P Staempfli; T Jaermann; S Kwiecinski; S Kollias
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

4.  Perfusion MRI before and after acetazolamide administration for assessment of cerebrovascular reserve capacity in patients with symptomatic internal carotid artery (ICA) occlusion: comparison with 99mTc-ECD SPECT.

Authors:  J Ma; J H Mehrkens; M Holtmannspoetter; R Linke; R Schmid-Elsaesser; H-J Steiger; H Brueckmann; R Bruening
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

Review 5.  Ultra-high-speed MR imaging.

Authors:  C P Davis; G C McKinnon; J F Debatin; G K von Schulthess
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 6.  Clinical MRI of acute ischemic stroke.

Authors:  R Gilberto González
Journal:  J Magn Reson Imaging       Date:  2012-08       Impact factor: 4.813

7.  Perfusion MR neuroimaging in patients undergoing balloon test occlusion of the internal carotid artery.

Authors:  E Michel; H Liu; K B Remley; A J Martin; M T Madison; J Kucharczyk; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

8.  Sodium MRI and the assessment of irreversible tissue damage during hyper-acute stroke.

Authors:  Fernando E Boada; Yongxian Qian; Edwin Nemoto; Tudor Jovin; Charles Jungreis; S C Jones; Jonathan Weimer; Vincent Lee
Journal:  Transl Stroke Res       Date:  2012-05-04       Impact factor: 6.829

9.  Estimation of perfusion properties with MR Fingerprinting Arterial Spin Labeling.

Authors:  Katherine L Wright; Yun Jiang; Dan Ma; Douglas C Noll; Mark A Griswold; Vikas Gulani; Luis Hernandez-Garcia
Journal:  Magn Reson Imaging       Date:  2018-03-12       Impact factor: 2.546

10.  Degeneracy in model parameter estimation for multi-compartmental diffusion in neuronal tissue.

Authors:  Ileana O Jelescu; Jelle Veraart; Els Fieremans; Dmitry S Novikov
Journal:  NMR Biomed       Date:  2015-11-29       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.